Delivery Order SPE2DB22D1017-SPE2DB24FG1DJ

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Multaq 400 mg tablets. The $4,120.50 firm fixed-price delivery order has a completion date of June 12, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies,...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract, valued at $9,698.52, is for the delivery of Multaq 400 mg tablets. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $15,744.77 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of July 24, 2024. Amerisourcebergen is delivering these pharmaceutical products to support military treatment facilities and other federal healthcare providers. This...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Multaq 400 mg tablets. The $26,758.04 delivery order was placed under an existing $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,850.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563556699 MULTAQ 400 MG TABLET 60S. The firm fixed price contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through multiple...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Multaq 400 mg tablets. The $18,267.20 firm fixed-price delivery order has an ultimate completion date of October 26, 2023 and was awarded on October 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $13,093.98 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, with a completion date of July 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $14,064.35, is a delivery order with a firm fixed price. The award provides Multaq 400 mg tablet 60s, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Multaq 400 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a total ceiling value of $2,777.16 and an ultimate completion date of March 14, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,297.44, is for the delivery of Multaq 400 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through July 9, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG1DJ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,829.48 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565122252 - Multaq 400 mg tablet, 60 count, with a completion date of July 12, 2024. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense's medical treatment programs and facilities globally. The contract does not have a set-aside designation.

Generated 10/10/24, 9:36 AM